Global Cord Blood
CORBF
$1.25
Share price
0.00%
Change (1 day)
-58.19%
Change (1 year)
Categories
Global Cord Blood (CORBF) - Total liabilities
Total liabilities on the balance sheet as of March 2022 : $0.57 B
According to Global Cord Blood's latest financial reports the company's total liabilities are $0.57 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Global Cord Blood - Total liabilities on balance sheet (from 2007 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-03-31 | $0.57 B | 7.42% |
| 2021-03-31 | $0.53 B | 14.09% |
| 2020-03-31 | $0.46 B | 0.67% |
| 2019-03-31 | $0.46 B | 7.43% |
| 2018-03-31 | $0.43 B | -10.52% |
| 2017-03-31 | $0.48 B | 5.23% |
| 2016-03-31 | $0.46 B | 11.17% |
| 2015-03-31 | $0.41 B | 17.33% |
| 2014-03-31 | $0.35 B | 25.86% |
| 2013-03-31 | $0.28 B | 200.25% |
| 2012-03-31 | $93.48 M | 30.2% |
| 2011-03-31 | $71.8 M | 115.19% |
| 2010-03-31 | $33.36 M | |
| 2008-12-31 | $8.32 M | 16.18% |
| 2007-12-31 | $7.16 M | 1.11% |
| 2006-12-31 | $7.08 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | $1.87 B | 226.41% | 🇺🇸 USA |
 National Healthcare
NHC | $0.40 B | -30.39% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.73 B | 28.62% | 🇺🇸 USA |
 Cryo-Cell CCEL | $72.25 M | -87.44% | 🇺🇸 USA |